A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
Start Date
4/16/2026
Completion Date
12/1/2026
Summary
The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a specific genotype.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Artificial Tear Run-in
licaminlimab
Vehicle of licaminlimab
Conditions
Locations
East West Eye Institute
Aliso Viejo, California 92656
United States
Orange County Ophthalmology
Garden Grove, California 92843
United States
Global Research Management
Glendale, California 91204
United States
LoBue Laser and Eye Medical Center
Murrieta, California 92562
United States
Eye Research Foundation
Newport Beach, California 92664
United States
North Bay Eye Associates, Inc.
Petaluma, California 94954
United States
Vision Institute
Colorado Springs, Colorado 80907
United States
Segal Drug Trials, Inc.
Delray Beach, Florida 33484
United States
Oculus Research, Inc.
Garner, North Carolina 27529
United States
CORE, Inc
Shelby, North Carolina 28150
United States
Scott & Christie and Associates
Cranberry Township, Pennsylvania 16066
United States
Erie Retina Research
Erie, Pennsylvania 16507
United States
Total Eye Care, PA
Memphis, Tennessee 38119
United States
Piedmont Eye Center, Inc.
Lynchburg, Virginia 24502
United States